Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
0.880
-0.060 (-6.38%)
At close: Jan 17, 2025, 4:00 PM
0.850
-0.030 (-3.41%)
After-hours: Jan 17, 2025, 7:49 PM EST
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $1.41 million as of January 17, 2025. Its market cap has decreased by -99.06% in one year.
Market Cap
1.41M
Enterprise Value
622.72K
1-Year Change
-99.06%
Ranking
Category
Stock Price
0.88
Market Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.55M to $1.41M, a decrease of -99.05%. That is a compound annual growth rate of -70.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 1.41M | -56.22% |
| Dec 31, 2024 | 3.22M | -92.33% |
| Dec 21, 2023 | 41.99M | -71.93% |
| Dec 30, 2022 | 149.59M | 4.03% |
| Dec 31, 2021 | 143.80M | -3.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |